{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:46:47Z","timestamp":1792446407552,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.bcp.2019.113681","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T11:33:22Z","timestamp":1572003202000},"page":"113681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Correlation between angiotensin 1\u20137-mediated Mas receptor expression with motor improvement, activated STAT3\/SOCS3 cascade, and suppressed HMGB-1\/RAGE\/NF-\u03baB signaling in 6-hydroxydopamine hemiparkinsonian rats"],"prefix":"10.1016","volume":"171","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9488-2320","authenticated-orcid":false,"given":"Mostafa A.","family":"Rabie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai A.","family":"Abd El Fattah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha N.","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalaal M.","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8819-9891","authenticated-orcid":false,"given":"Hanan S.","family":"El-Abhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.bcp.2019.113681_b0005","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0005-2728(98)00114-5","article-title":"Mitochondrial dysfunction in neurodegenerative diseases","volume":"1366","author":"Beal","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"issue":"10 Suppl 4","key":"10.1016\/j.bcp.2019.113681_b0010","first-page":"S24","article-title":"The pathogenesis of cell death in Parkinson's disease","volume":"66","author":"Jenner","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bcp.2019.113681_b0015","series-title":"Paracrine and Intracrine Angiotensin 1\u20137\/Mas Receptor Axis in the Substantia Nigra of Rodents, Monkeys, and Humans","author":"Costa-Besada","year":"2017"},{"issue":"3","key":"10.1016\/j.bcp.2019.113681_b0020","first-page":"257","article-title":"Aging, Angiotensin system and dopaminergic degeneration in the substantia nigra","volume":"2","author":"Labandeira-Garcia","year":"2011","journal-title":"Aging Dis."},{"issue":"4","key":"10.1016\/j.bcp.2019.113681_b0025","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/npp.2010.225","article-title":"Angiotensin II AT1 receptor blockade ameliorates brain inflammation","volume":"36","author":"Benicky","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.bcp.2019.113681_b0030","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.mce.2008.11.003","article-title":"NADPH oxidases and angiotensin II receptor signaling","volume":"302","author":"Garrido","year":"2009","journal-title":"Mol. Cell Endocrinol."},{"issue":"6","key":"10.1016\/j.bcp.2019.113681_b0035","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/glia.22479","article-title":"NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administration","volume":"61","author":"Qin","year":"2013","journal-title":"Glia"},{"issue":"11","key":"10.1016\/j.bcp.2019.113681_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142664","article-title":"Angiotensin-(1\u20137) Attenuates Kidney Injury Due to Obstructive Nephropathy in Rats","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS. One."},{"issue":"14","key":"10.1016\/j.bcp.2019.113681_b0045","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1\u20137) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bcp.2019.113681_b0050","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.peptides.2013.11.006","article-title":"An orally active angiotensin-(1\u20137) inclusion compound and exercise training produce similar cardiovascular effects in spontaneously hypertensive rats","volume":"51","author":"Bertagnolli","year":"2014","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.bcp.2019.113681_b0055","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1161\/01.HYP.38.1.95","article-title":"Bradykinin potentiation by angiotensin-(1\u20137) and ACE inhibitors correlates with A","volume":"38","author":"Tom","year":"2001","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.bcp.2019.113681_b0060","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1113\/expphysiol.2011.058578","article-title":"Cerebroprotection by angiotensin-(1\u20137) in endothelin-1-induced ischaemic stroke","volume":"96","author":"Mecca","year":"2011","journal-title":"Exp. Physiol"},{"issue":"1","key":"10.1016\/j.bcp.2019.113681_b0065","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3233\/JAD-150642","article-title":"Intracerebroventricular Infusion of Angiotensin-(1\u20137) Ameliorates Cognitive Impairment and Memory Dysfunction in a Mouse Model of Alzheimer's Disease","volume":"53","author":"Uekawa","year":"2016","journal-title":"J. Alzheimers. Dis."},{"issue":"2","key":"10.1016\/j.bcp.2019.113681_b0070","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1177\/1352458508097923","article-title":"Angiotensin-converting enzyme (ACE) and ACE2 levels in the cerebrospinal fluid of patients with multiple sclerosis","volume":"15","author":"Kawajiri","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.bcp.2019.113681_b0075","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bcp.2018.01.047","article-title":"Angiotensin 1\u20137 ameliorates 6-hydroxydopamine lesions in hemiparkinsonian rats through activation of MAS receptor\/PI3K\/Akt\/BDNF pathway and inhibition of angiotensin II type-1 receptor\/NF-kappaB axis","volume":"151","author":"Rabie","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2019.113681_b0080","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.brainres.2010.02.031","article-title":"Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease","volume":"1328","author":"Khan","year":"2010","journal-title":"Brain Res."},{"issue":"1\u20133","key":"10.1016\/j.bcp.2019.113681_b0085","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejphar.2008.10.005","article-title":"Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats","volume":"600","author":"Jin","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2019.113681_b0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neuroscience.2015.11.059","article-title":"Role of adenosine A2A receptor in cerebral ischemia reperfusion injury: Signaling to phosphorylated extracellular signal-regulated protein kinase (pERK1\/2)","volume":"314","author":"Mohamed","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.bcp.2019.113681_b0095","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainres.2014.05.019","article-title":"Angiotensin-(1\u20137) improves cognitive function in rats with chronic cerebral hypoperfusion","volume":"1573","author":"Xie","year":"2014","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.bcp.2019.113681_b0100","first-page":"904","article-title":"Pharmacological preconditioning of the brain: a possible interplay between opioid and calcitonin gene related peptide transduction systems","volume":"60","author":"Rehni","year":"2008","journal-title":"Pharmacol. Rep."},{"issue":"5","key":"10.1016\/j.bcp.2019.113681_b0105","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0028-3908(00)00005-8","article-title":"CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury","volume":"39","author":"Schallert","year":"2000","journal-title":"Neuropharmacology"},{"issue":"5\u20136","key":"10.1016\/j.bcp.2019.113681_b0110","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00008877-200609000-00004","article-title":"Behavioral phenotypes and pharmacology in genetic mouse models of Parkinsonism","volume":"17","author":"Fleming","year":"2006","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.bcp.2019.113681_b0115","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"issue":"4","key":"10.1016\/j.bcp.2019.113681_b0120","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"3","key":"10.1016\/j.bcp.2019.113681_b0125","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1096\/fj.03-0983fje","article-title":"Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase","volume":"18","author":"Zhang","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2019.113681_b0130","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1742-2094-9-124","article-title":"Endogenous dynorphin protects against neurotoxin-elicited nigrostriatal dopaminergic neuron damage and motor deficits in mice","volume":"9","author":"Wang","year":"2012","journal-title":"J. Neuroinflammation."},{"key":"10.1016\/j.bcp.2019.113681_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2019.152256","article-title":"Luteolin-7-O-glucoside protects dopaminergic neurons by activating estrogen-receptor-mediated signaling pathway in MPTP-induced mice","volume":"426","author":"Qin","year":"2019","journal-title":"Toxicology"},{"key":"10.1016\/j.bcp.2019.113681_b0140","doi-asserted-by":"crossref","first-page":"30459","DOI":"10.1038\/srep30459","article-title":"IL-10 Promotes Neurite Outgrowth and Synapse Formation in Cultured Cortical Neurons after the Oxygen-Glucose Deprivation via JAK1\/STAT3 Pathway","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2019.113681_b0145","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neuroscience.2019.07.020","article-title":"Colivelin Rescues Ischemic Neuron and Axons Involving JAK\/STAT3 Signaling Pathway","volume":"416","author":"Zhao","year":"2019","journal-title":"Neuroscience"},{"issue":"4\u20135","key":"10.1016\/j.bcp.2019.113681_b0150","first-page":"341","article-title":"Role of signal transducer and activator of transcription 3 in neuronal survival and regeneration","volume":"19","author":"Dziennis","year":"2008","journal-title":"Rev. Neurosci."},{"issue":"2\u20133","key":"10.1016\/j.bcp.2019.113681_b0155","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s12035-010-8102-z","article-title":"Reperfusion and neurovascular dysfunction in stroke: from basic mechanisms to potential strategies for neuroprotection","volume":"41","author":"Jung","year":"2010","journal-title":"Mol. Neurobiol."},{"issue":"11","key":"10.1016\/j.bcp.2019.113681_b0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050874","article-title":"Protective role of STAT3 in NMDA and glutamate-induced neuronal death: negative regulatory effect of SOCS3","volume":"7","author":"Park","year":"2012","journal-title":"PLoS. One."},{"issue":"15","key":"10.1016\/j.bcp.2019.113681_b0165","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1073\/pnas.1015239108","article-title":"In vivo imaging reveals a phase-specific role of STAT3 during central and peripheral nervous system axon regeneration","volume":"108","author":"Bareyre","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.bcp.2019.113681_b0170","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.conb.2010.03.013","article-title":"Neuronal intrinsic barriers for axon regeneration in the adult CNS","volume":"20","author":"Sun","year":"2010","journal-title":"Curr. Opin. Neurobiol."},{"issue":"24","key":"10.1016\/j.bcp.2019.113681_b0175","doi-asserted-by":"crossref","first-page":"8019","DOI":"10.1523\/JNEUROSCI.16-24-08019.1996","article-title":"Influence of cocaine on the JAK-STAT pathway in the mesolimbic dopamine system","volume":"16","author":"Berhow","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2019.113681_b0180","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.3389\/fmicb.2017.02431","article-title":"SOCS Proteins as Regulators of Inflammatory Responses Induced by Bacterial Infections: A Review","volume":"8","author":"Duncan","year":"2017","journal-title":"Front Microbiol."},{"issue":"10","key":"10.1016\/j.bcp.2019.113681_b0185","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1080\/01616412.2017.1352187","article-title":"Neuroprotective effect of G(14)-humanin on global cerebral ischemia\/reperfusion by activation of SO","volume":"39","author":"Gao","year":"2017","journal-title":"Neurol. Res."},{"issue":"32","key":"10.1016\/j.bcp.2019.113681_b0190","doi-asserted-by":"crossref","first-page":"27189","DOI":"10.1074\/jbc.M112.346932","article-title":"Gemfibrozil, a lipid-lowering drug, induces suppressor of cytokine signaling 3 in glial cells: implications for neurodegenerative disorders","volume":"287","author":"Ghosh","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2019.113681_b0195","article-title":"Propofol mediates signal transducer and activator of transcription 3 activation and crosstalk with phosphoinositide 3-kinase\/AKT","volume":"3","author":"Shravah","year":"2014","journal-title":"JAKSTAT."},{"key":"10.1016\/j.bcp.2019.113681_b0200","doi-asserted-by":"crossref","DOI":"10.1100\/2012\/756357","article-title":"A review: inflammatory process in Alzheimer's disease, role of cytokines","volume":"2012","author":"Rubio-Perez","year":"2012","journal-title":"ScientificWorldJournal."},{"key":"10.1016\/j.bcp.2019.113681_b0205","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3389\/fimmu.2019.01267","article-title":"IL-10\/STAT3\/SOCS3 Axis Is Involved in the Anti-inflammatory Effect of Benznidazole","volume":"10","author":"Cevey","year":"2019","journal-title":"Front Immunol."},{"issue":"11","key":"10.1016\/j.bcp.2019.113681_b0210","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1164\/rccm.200811-1678OC","article-title":"Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension","volume":"179","author":"Ferreira","year":"2009","journal-title":"Am. J. Respir. Crit Care Med."},{"issue":"2","key":"10.1016\/j.bcp.2019.113681_b0215","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1007\/s12035-014-9042-9","article-title":"Naringenin Suppresses Neuroinflammatory Responses Through Inducing Suppressor of Cytokine Signaling 3 Expression","volume":"53","author":"Wu","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2019.113681_b0220","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.brainres.2014.03.036","article-title":"Hydroxy-safflor yellow A attenuates Abeta(1)(-)(4)(2)-induced inflammation by modulating the JAK2\/STAT3\/NF-kappaB pathway","volume":"1563","author":"Zhang","year":"2014","journal-title":"Brain Res."},{"issue":"10","key":"10.1016\/j.bcp.2019.113681_b0225","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.1007\/s12035-018-0966-3","article-title":"Stimulation of ACE2\/ANG(1\u20137)\/Mas Axis by Diminazene Ameliorates Alzheimer's Disease in the D-Galactose-Ovariectomized Rat Model: Role of PI3K\/Akt Pathway","volume":"55","author":"Kamel","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"8","key":"10.1016\/j.bcp.2019.113681_b0230","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.it.2009.07.001","article-title":"SOCS1 and SOCS3 in the control of CNS immunity","volume":"30","author":"Baker","year":"2009","journal-title":"Trends Immunol."},{"issue":"10","key":"10.1016\/j.bcp.2019.113681_b0235","doi-asserted-by":"crossref","first-page":"894","DOI":"10.2174\/1567205015666180507104755","article-title":"Upregulation of Suppressor of Cytokine Signaling 3 in Microglia by Cinnamic Acid","volume":"15","author":"Chakrabarti","year":"2018","journal-title":"Curr. Alzheimer Res."},{"issue":"9","key":"10.1016\/j.bcp.2019.113681_b0240","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.4049\/jimmunol.1000773","article-title":"The PPE18 protein of Mycobacterium tuberculosis inhibits NF-kappaB\/rel-mediated proinflammatory cytokine production by upregulating and phosphorylating suppressor of cytokine signaling 3 protein","volume":"186","author":"Nair","year":"2011","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2019.113681_b0245","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1128\/IAI.01412-06","volume":"75","author":"Olson","year":"2007","journal-title":"Infect. Immun."},{"issue":"7","key":"10.1016\/j.bcp.2019.113681_b0250","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/me.2005-0301","article-title":"Suppressor of cytokine Signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6\/TAK1 complex","volume":"20","author":"Frobose","year":"2006","journal-title":"Mol. Endocrinol."},{"issue":"6","key":"10.1016\/j.bcp.2019.113681_b0255","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1159\/000374047","article-title":"Angiotensin-(1\u20137) Attenuates Angiotensin II-Induced ICAM-1, VCAM-1, and MCP-1 Expression via the MAS Receptor Through Suppression of P38 and NF-kappaB Pathways in HUVECs","volume":"35","author":"Liang","year":"2015","journal-title":"Cell Physiol Biochem."},{"issue":"1","key":"10.1016\/j.bcp.2019.113681_b0260","first-page":"409","article-title":"Angiotensin-converting enzyme 2-angiotensin (1\u20137)-Mas axis prevents pancreatic acinar cell inflammatory response via inhibition of the p38 mitogen-activated protein kinase\/nuclear factor-kappaB pathway","volume":"41","author":"Yu","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"7","key":"10.1016\/j.bcp.2019.113681_b0265","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1111\/j.1476-5381.2012.02105.x","article-title":"Suppressing inflammation by inhibiting the NF-kappaB pathway contributes to the neuroprotective effect of angiotensin-(1\u20137) in rats with permanent cerebral ischaemia","volume":"167","author":"Jiang","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2019.113681_b0270","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/jnc.13386","article-title":"Direct anti-inflammatory effects of angiotensin-(1\u20137) on microglia","volume":"136","author":"Liu","year":"2016","journal-title":"J. Neurochem."},{"issue":"49","key":"10.1016\/j.bcp.2019.113681_b0275","doi-asserted-by":"crossref","first-page":"14109","DOI":"10.1073\/pnas.1612668113","article-title":"Role of the receptor Mas in macrophage-mediated inflammation in vivo","volume":"113","author":"Hammer","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"48","key":"10.1016\/j.bcp.2019.113681_b0280","doi-asserted-by":"crossref","first-page":"18314","DOI":"10.1073\/pnas.0606528103","article-title":"Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death","volume":"103","author":"Yu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"24","key":"10.1016\/j.bcp.2019.113681_b0285","doi-asserted-by":"crossref","first-page":"17845","DOI":"10.1074\/jbc.M701465200","article-title":"Activation of poly(ADP)-ribose polymerase (PARP-1) induces release of the pro-inflammatory mediator HMGB1 from the nucleus","volume":"282","author":"Ditsworth","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2019.113681_b0290","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1523\/JNEUROSCI.3732-10.2011","article-title":"HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration","volume":"31","author":"Gao","year":"2011","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.bcp.2019.113681_b0295","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/jnr.20340","article-title":"High mobility group box protein-1 inhibits microglial Abeta clearance and enhances Abeta neurotoxicity","volume":"78","author":"Takata","year":"2004","journal-title":"J. Neurosci. Res."},{"issue":"5\u20136","key":"10.1016\/j.bcp.2019.113681_b0300","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000444188","article-title":"Effect of Angiotensin-(1\u20137) on Aortic Response, TNF-alpha, IL-1beta and Receptor for Advanced Glycation Endproduct in Rat's Adjuvant-Induced Arthritis","volume":"97","author":"Acikalin","year":"2016","journal-title":"Pharmacology"},{"issue":"1","key":"10.1016\/j.bcp.2019.113681_b0305","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00109-015-1356-1","article-title":"Angiotensin-converting enzyme 2 inhibits high-mobility group box 1 and attenuates cardiac dysfunction post-myocardial ischemia","volume":"94","author":"Qi","year":"2016","journal-title":"J. Mol. Med. (Berl)"},{"issue":"6","key":"10.1016\/j.bcp.2019.113681_b0310","doi-asserted-by":"crossref","first-page":"H1985","DOI":"10.1152\/ajpheart.01145.2002","article-title":"Systemic and regional hemodynamic effects of angiotensin-(1\u20137) in rats","volume":"284","author":"Sampaio","year":"2003","journal-title":"Am. J. Physiol Heart Circ. Physiol"},{"issue":"5","key":"10.1016\/j.bcp.2019.113681_b0315","doi-asserted-by":"crossref","first-page":"F841","DOI":"10.1152\/ajprenal.2000.279.5.F841","article-title":"Pathways for angiotensin-(1\u20137) metabolism in pulmonary and renal tissues","volume":"279","author":"Allred","year":"2000","journal-title":"Am. J. Physiol Renal Physiol"},{"key":"10.1016\/j.bcp.2019.113681_b0320","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2119\/molmed.2015.00022","article-title":"Angiotensin-(1\u20137) Suppresses Hepatocellular Carcinoma Growth and Angiogenesis via Complex Interactions of Angiotensin II Type 1 Receptor, Angiotensin II Type 2 Receptor and Mas Receptor","volume":"21","author":"Liu","year":"2015","journal-title":"Mol. Med."},{"issue":"6","key":"10.1016\/j.bcp.2019.113681_b0325","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1161\/HYPERTENSIONAHA.116.08118","article-title":"Cardioprotective Angiotensin-(1\u20137) Peptide Acts as a Natural-Biased Ligand at the Angiotensin II Type 1 Receptor","volume":"68","author":"Galandrin","year":"2016","journal-title":"Hypertension"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219303806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219303806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:08:08Z","timestamp":1757768888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295219303806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":65,"alternative-id":["S0006295219303806"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2019.113681","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation between angiotensin 1\u20137-mediated Mas receptor expression with motor improvement, activated STAT3\/SOCS3 cascade, and suppressed HMGB-1\/RAGE\/NF-\u03baB signaling in 6-hydroxydopamine hemiparkinsonian rats","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2019.113681","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113681"}}